TCL Archive NCAB May Make Its Recommendation On Comprehensive Center Issues At September Meeting August 5, 1988
TCL Archive Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer February 25, 2011
TCL Archive NIH Emerges From Republican Revolution With Another Increase in Appropriations October 4, 1996
TCL Archive In Brief: Four To Share In $100,000 Hammer Prize; Oldham To Head New Genetic Engineering Firm In Texas February 3, 1984
TCL Archive Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival November 29, 2013
